Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
BioMed Central, 2015
Online
academicJournal
Zugriff:
Titel: |
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
|
---|---|
Autor/in / Beteiligte Person: | Powderly, John ; Cote, Gregory ; Flaherty, Keith ; Szmulewitz, Russell Z ; Ribas, Antoni ; Weber, Jeffrey ; Loo, Deryk ; Baughman, Jan ; Chen, Francine ; Moore, Paul ; Bonvini, Ezio ; Vasselli, James ; Wigginton, Jon ; Cohen, Roger ; Burris, Howard ; Chmielowski, Bartosz |
Link: | |
Veröffentlichung: | BioMed Central, 2015 |
Medientyp: | academicJournal |
ISSN: | 2051-1426 (print) |
DOI: | 10.1186/2051-1426-3-S2-O8 |
Sonstiges: |
|